Omega Diagnostics Group PLC of Alva, Scotland at MEDICA 2018 in Düsseldorf -- MEDICA - World Forum for Medicine

Omega Diagnostics Group PLC

Omega House, Hillfoots Business Village, FK12 5DQ Alva, Scotland
United Kingdom of Great Britain and Northern Ireland
Telephone +44 1259 763030
Fax +44 1259 761853

This company is co-exhibitor of
Gambica Association Limited

Hall map

MEDICA 2018 hall map (Hall 3A): stand 3AC02-1

Fairground map

MEDICA 2018 fairground map: Hall 3A

Our range of products

Product categories

  • 03  Diagnostics
  • 03.02  Immunochemistry testing, immunology testing
  • 03.02.02  Diagnostic rapid tests

Diagnostic rapid tests

Our products

Product category: Diagnostic rapid tests


PATHOZYME® Ferritin is an enzyme-immunoassay (ELISA) test for the detection and quantification of Ferritin in human serum. The measurement of Ferritin can determine changes in body iron storage. This is useful for the detection of iron-deficiency anaemia and as an aid in the evaluation of clinical conditions not related to iron storage, including inflammation, chronic liver disease and malignancy.

More Less

Product category: Diagnostic rapid tests


AVITEX® is a range of latex serology tests featuring an easy-to-use 'NO SERUM DILUTION' test format. AVITEX® Autoimmunity products are standardised against recognised standards, where appropriate, to ensure the correct serological activity, sensitivity and specificity. Positive and negative controls are included to monitor the performance of the assays. Different pack sizes make the products convenient for large and small laboratories.

More Less

About us

Company details

Originally founded in Scotland in 1987, Omega Diagnostics Ltd's global reputation stems from beginnings as a manufacturer of tests for a range of infectious diseases such as syphilis, dengue fever and malaria. Our export success was officially recognised with the Queen’s Award for Export Achievement in 1993, providing a solid foundation for future success.
In 2006, Omega Diagnostics Group PLC was formed with a strategy to acquire additional products through acquisitions and now focuses on selling a wide range of specialist products, primarily in the immunoassay, in vitro diagnostics (IVD) market within three segments: allergy and autoimmune, food intolerance and infectious disease.

With our global headquarters based in Scotland, we have subsidiaries in Littleport (UK), Devon (UK) and Mumbai (India), with each site possessing ISO 13485 and ISO 9001, and compliant with directive 98/79/EC, on In Vitro Diagnostic (IVD) Medical Devices.

Our diagnostic kits and systems are found in hospitals, blood banks, clinics and laboratories around the world and produce information used by physicians and practitioners to diagnose disease, make treatment decisions and monitor patients.

Our product range was extended following the acquisition of Genesis Diagnostics Ltd and Cambridge Nutritional Sciences Ltd in September 2007, giving our customers access to tests for the fast-growing area of food intolerance testing, as well as those for autoimmune diseases, including anaemia, connective tissue disease and renal disease.

In 2010, Omega Diagnostics Group acquired the IVD division of allergy and specific immunotherapy specialist Allergopharma Joachim Ganzer KG, giving further access to a range of allergy tests for over 600 allergens.

In 2018, a restructure of our operations was carried out whereby our four UK companies were amalgamated into one entity, Omega Diagnostics Ltd.

Today, we are one of the UK's leading companies in the fast growing area of immunoassay and we have a global presence in over 100 countries worldwide.

More Less

Company data



Area of business